How to medicate for trichomoniasis vaginitis

Trichomonas vaginitis is a common form of vaginitis caused by the protozoan *Trichomonas vaginalis*. Its typical manifestations include increased vaginal discharge accompanied by pruritus vulvae. The discharge is characteristically thin, purulent, yellow-green, and frothy. So, how is trichomonas vaginitis treated pharmacologically? Let’s take a closer look.

Pharmacological Management of Trichomonas Vaginitis

The standard treatment involves oral administration of metronidazole or tinidazole. Oral metronidazole achieves a cure rate exceeding 90%. Sexual partners should also receive concurrent treatment, and sexual intercourse must be avoided during therapy. Additionally, underwear, towels, and washbasins used by the patient should be boiled for 5–10 minutes to eradicate the pathogen.

Because trichomonas vaginitis may coexist with infections of the urethra, paraurethral glands, and vestibular glands, systemic antimicrobial therapy is required. The mainstay drugs are oral metronidazole or tinidazole. For initial treatment, a single high-dose oral regimen of either metronidazole or tinidazole may be selected, achieving cure rates of 90–95%.

Alcohol consumption must be strictly avoided during treatment and for at least three days after discontinuation of medication. Breastfeeding is not recommended during treatment in lactating women. Moreover, sexual partners must undergo simultaneous treatment, and both patients and their partners should be advised to avoid unprotected intercourse until cure is confirmed. Specific dosing regimens should be determined following consultation with a gynecologist at a local hospital.

The above health information is for general reference only. Individuals should seek evaluation at an accredited medical institution and obtain diagnosis and management guidance from qualified healthcare professionals. Self-diagnosis or self-treatment is strongly discouraged.